Technical Analysis for AVCT - Avacta Group Plc

Grade Last Price % Change Price Change
C 234.9 -4.51% -11.10
AVCT closed down 3.91 percent on Thursday, April 22, 2021, on 1.63 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical AVCT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish -4.51%
Calm After Storm Range Contraction -4.51%
Multiple of Ten Bearish Other -4.51%
Crossed Above 20 DMA Bullish -8.24%
Pocket Pivot Bullish Swing Setup -8.24%
Slingshot Bullish Bullish Swing Setup -8.24%
Calm After Storm Range Contraction -8.24%
Multiple of Ten Bullish Other -8.24%
20 DMA Resistance Bearish -4.04%
Pocket Pivot Bullish Swing Setup -4.04%
Older End-of-Day Signals for AVCT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 17 minutes ago
Possible NR7 about 1 hour ago
3x Volume Pace about 5 hours ago
2x Volume Pace about 5 hours ago
1.5x Volume Pace about 5 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avacta Group Plc Description

Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Science Medicine Clinic Tools Life Sciences Branches Of Biology Medical Specialties Oncology Immunology Disorders Immune System Assay Antibodies

Is AVCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 291.8
52 Week Low 88.5001
Average Volume 3,784,613
200-Day Moving Average 164.43
50-Day Moving Average 224.18
20-Day Moving Average 245.90
10-Day Moving Average 250.04
Average True Range 24.41
ADX 20.74
+DI 29.04
-DI 15.38
Chandelier Exit (Long, 3 ATRs ) 218.56
Chandelier Exit (Short, 3 ATRs ) 271.01
Upper Bollinger Band 278.10
Lower Bollinger Band 213.69
Percent B (%b) 0.5
BandWidth 26.19
MACD Line 5.68
MACD Signal Line 8.31
MACD Histogram -2.6307
Fundamentals Value
Market Cap 621.53 Million
Num Shares 253 Million
EPS -11.60
Price-to-Earnings (P/E) Ratio -21.21
Price-to-Sales 31.35
Price-to-Book 4.14
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 293.85
Resistance 3 (R3) 297.63 285.47 285.88
Resistance 2 (R2) 285.47 273.28 283.58 283.21
Resistance 1 (R1) 265.73 265.75 275.60 261.95 280.56
Pivot Point 253.57 253.57 258.50 251.67 253.57
Support 1 (S1) 233.83 241.38 243.70 230.05 211.44
Support 2 (S2) 221.67 233.85 219.77 208.79
Support 3 (S3) 201.93 221.67 206.12
Support 4 (S4) 198.15